Chemotherapy Current Events | Chemotherapy News | 11
|
| Page
11 of
25 |
498 Results |
|
|
|
Sort By:
Page Views | Date |
Biopsies of the internal mammary sentinel nodes may improve patients' chances of survival
Surgeons at a hospital in the Netherlands are pioneering the taking of biopsies from lymph nodes behind the sternum (breast bone) at the same time as they take the more usual biopsies of the lymph nodes under the armpits, the 3rd European Breast Cancer Conference in Barcelona heard today (Friday 22 March). Dr Fred van der Ent, a senior surgeon at... view more... (2002-03-20)
Research Will Push Forward Fight Against Leukaemia
A project which aims to make laboratory-grown leukaemia cells change form and then be used to prime a patient's own immune system to kill off malignant cells has begun in Edinburgh. If successful, the study could give clinicians a way of destroying residual leukaemic cells which are undetectable by microscope. The findings could be helpful in the... view more... (2002-10-25)
Joining forces against cancer
In cancer therapy, the best results are often achieved by combining treatments such as chemotherapy, radiotherapy and surgery. view more (2008-09-17)
New Approach for the Treatment of Malignant Brain Tumors
Initial chemotherapy alone after surgery is just as successful as initial radiation therapy for patients from whom a very malignant brain tumor (anaplastic glioma) was removed. With this treatment, the patients survive on average > 30 months without a recurrence. view more (2009-10-01)
FLT PET Assesses Treatment Response on Tumor Growth—Not Size—With Non-Hodgkin's Lymphoma
Positron emission tomography (PET)—with the radiolabeled thymidine analog [18F]Fluorothymidine (FLT)—is "a promising, sensitive tool" for assessing drug effects on tumor growth in patients with diffuse large B-cell lymphoma. view more (2006-06-07)
NovoCure presents results from breast cancer pilot study
NovoCure announced today that it presented the results from a single-arm pilot trial evaluating the Novo-TTF, a non-invasive portable medical device, combined with neo-adjuvant chemotherapy for the treatment of patients with locally advanced breast cancer. view more (2008-04-15)
Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
In pre-clinical studies, vitamin C appears to substantially reduce the effectiveness of anticancer drugs, say researchers at Memorial Sloan-Kettering Cancer Center. view more (2008-10-01)
Trimming the fat boosts blood recovery after marrow transplant
Seeking ways to improve blood recovery after chemotherapy or bone marrow transplant, researchers at Children's Hospital Boston have discovered that fat cells, which accumulate in bone marrow as people age, inhibit the marrow's ability to produce new blood cells. view more (2009-06-11)
Co-operation between GSF and clinic improves outlook for sarcoma patients: Effectiveness of local, deep hyperthermia proved in phase III study
Hyperthermia, combined with chemotherapy, improves the chances of healing and survival of patients with low-lying, soft tissue sarcomas. view more (2007-07-16)
Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to researchers at Oxford BioMedica (UK) Ltd. view more (2007-08-02)
Older breast cancer patients may be under-diagnosed and under-treated
Elderly patients with breast cancer who received care in a community hospital setting may have been under-diagnosed, under-staged and under-treated. view more (2006-10-17)
Common chemotherapy drug triggers fatal allergic reactions
A chemotherapy drug that is supposed to help save cancer patients' lives, instead resulted in life-threatening and sometimes fatal allergic reactions. view more (2009-06-09)
Intensity-modulated radiation therapy reduces side effects for cervical cancer
Preliminary results from a University of Pittsburgh study evaluating extended-field intensity-modulated radiation therapy (IMRT) for cervical cancer found that it resulted in significantly reduced side effects and outcomes comparable to standard radiotherapy. view more (2006-11-08)
Pre-clinical studies identify novel ways to enhance effect of chemotherapy
Results call for clinical trials with Glivec in combination with other chemotherapy Frankfurt, Germany: Researchers have found that blocking the action of a growth factor on tumour stroma cells[1] increases the uptake of cancer drugs by the tumour. The findings could be crucial for efforts to make standard chemotherapy work better. Kristian... view more... (2002-11-17)
New type of drug shrinks primary breast cancer tumors significantly in just 6 weeks
A drug that targets the cell surface receptors that play an important role in many types of cancer can bring about significant tumour regression in breast cancer after only six weeks of use. view more (2008-04-17)
New treatment option studied for bladder cancer
A chemotherapy regimen for patients with advanced bladder cancer who aren't eligible for standard treatment is under study at the Medical College of Georgia. view more (2007-10-30)
VEGF Trap shows activity in patients with advanced ovarian cancer
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents. view more (2007-06-04)
PMH finding may help some tonsil cancer patients avoid chemotherapy
Clinical researchers at Princess Margaret Hospital (PMH) have confirmed that patients with oropharyngeal squamous cell cancer ("tonsil cancer") harbour a common type of human papilloma virus (HPV16), but also that such cancers are very sensitive to radiation. view more (2009-11-04)
Microarray provides 3 genomic guides to breast cancer treatment decisions
Three genomic tests separately predict the likelihood that a patient's breast cancer will reoccur after surgery without additional treatment, and the cancer's vulnerability to chemotherapy or hormone therapy. view more (2007-09-07)
Herceptin treatment lowers recurrence rate in early breast cancer
The targeted drug trastuzumab, or Herceptin, previously shown to prolong survival in advanced breast cancer, dramatically reduced the chances of recurrence in patients with early-stage disease when given for one year following standard chemotherapy. view more (2005-10-20)
|
|
| Page
11 of
25 |
498 Results |
|
|
|
Sort By:
Page Views | Date |
|
